ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer

International Journal of Oncology
Keisuke TaniuchiToshiji Saibara

Abstract

Rho guanine nucleotide exchange factor 4 (ARHGEF4) is a guanine nucleotide exchange factor that is specific for Rac1 and Cdc42. The aim of the present study was to investigate the role of ARHGEF4 in the motility and invasiveness of pancreatic cancer cells. Evaluation of an immunohistochemical staining of 102 resected pancreatic cancer samples demonstrated that high ARHGEF4 expression was correlated with an independent predictor of worse overall survival in univariate and multivariate analyses. Immunofluorescence analyses and Matrigel invasion assays demonstrated that suppression of ARHGEF4 inhibited the formation of membrane protrusions, and in turn inhibited cell motility and invasion. A phosphoprotein array analysis demonstrated that knockdown of ARHGEF4 decreased phosphorylated extracellular signal-regulated kinase (ERK)1/2 and glycogen synthase kinase-3 (GSK-3)α/β in pancreatic cancer cells, and ERK1/2 and GSK-3α/β were associated with ARHGEF4-related motility and invasiveness through an increase in cell protrusions. These results suggested that ARHGEF4 stimulates ERK1/2 and GSK-3α/β, and provided evidence that ARHGEF4 promotes cell motility and invasiveness. Inhibition of ARHGEF4 may be a novel approach to a targeted molec...Continue Reading

References

Jun 30, 2000·Biochemical and Biophysical Research Communications·S ThiesenH G Nothwang
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BowmanR Jove
Feb 25, 2003·Nature Cell Biology·Yoshihiro KawasakiTetsu Akiyama
Oct 16, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Aleodor AndeaVolkan N Adsay
May 29, 2004·Cancer Treatment and Research·Victor A Levin
Jun 1, 2004·Journal of Cell Science·Ursula Rescher, Volker Gerke
May 18, 2005·Journal of Neuroscience Research·Attila FarkasIstván A Krizbai
Dec 5, 2006·Oncogene·T Akiyama, Y Kawasaki
Aug 21, 2007·Nature Structural & Molecular Biology·Natalia MitinKent L Rossman
Jul 26, 2008·Journal of Cell Science·Reina E ItohMichiyuki Matsuda
Jun 16, 2009·The Journal of Biological Chemistry·Yoshihiro KawasakiTetsu Akiyama
Nov 10, 2009·The Journal of Biological Chemistry·Yoshihiro KawasakiTetsu Akiyama
Nov 21, 2009·Anti-cancer Agents in Medicinal Chemistry·Katsuyoshi MiyashitaToshinari Minamoto
Apr 27, 2010·Pancreas·Emily L DeerSean J Mulvihill
Jun 30, 2012·Neoplasia : an International Journal for Oncology Research·Keisuke TaniuchiToshiji Saibara
Dec 17, 2014·Neoplasia : an International Journal for Oncology Research·Keisuke TaniuchiToshiji Saibara
Jul 28, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Makiko TsuboiToshiji Saibara
Dec 7, 2016·Journal of Experimental & Clinical Cancer Research : CR·Aki TanouchiToshiji Saibara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.